Germany
Japan
United Kingdom
China
qSTAR qPCR primer pairs against Mus musculus gene Tnf
Products
View as table DownloadTNF (Myc-DDK-tagged)-Human tumor necrosis factor (TNF)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
qSTAR qPCR primer pairs against Homo sapiens gene TNF
| Component | 1 vial of lyophilized qSTAR qPCR primer mix (1 nmol each primer, sufficient for 200 reactions) |
Recombinant protein of human tumor necrosis factor (TNF superfamily, member 2) (TNF)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
Special Offer: Get a 20% discount on this product. Use code: "MVPro20".
Tnf (Myc-DDK-tagged) - Mouse tumor necrosis factor (Tnf)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
TNF (untagged)-Human tumor necrosis factor (TNF)
| Vector | pCMV6-XL5 |
| Tag | Tag Free |
| Mammalian Cell Selection | None |
TNF (GFP-tagged) - Human tumor necrosis factor (TNF)
| Vector | pCMV6-AC-GFP |
| Tag | TurboGFP |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
Tnf (untagged) - Mouse tumor necrosis factor (Tnf), (10ug)
| Vector | pCMV6-Entry |
| Tag | Tag Free |
| Mammalian Cell Selection | Neomycin |
Lenti ORF particles, Tnf (GFP-tagged ORF) - Rat tumor necrosis factor (TNF superfamily, member 2) (Tnf), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
- LentiORF®
-
USD 820.00
3 Weeks
Lenti ORF particles, TNF (Myc-DDK tagged) - Human tumor necrosis factor (TNF), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
- LentiORF®
-
USD 820.00
3 Weeks
Lenti ORF particles, TNF (mGFP-tagged) - Human tumor necrosis factor (TNF), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
- LentiORF®
-
Lenti ORF particles, Tnf (Myc-DDK-tagged ORF) - Rat tumor necrosis factor (TNF superfamily, member 2) (Tnf), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
- LentiORF®
-
Recombinant protein of human soluble form of TNF-alpha with His and DDK tags, expressed in human cells
| Tag | N-His/DDK |
| Expression Host | HEK293 |
Tnf (Myc-DDK-tagged ORF) - Rat tumor necrosis factor (TNF superfamily, member 2) (Tnf), (10 ug)
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
Purified recombinant protein of Human tumor necrosis factor (TNF).
| Tag | Tag Free |
| Expression Host | E. coli |
Transient overexpression lysate of tumor necrosis factor (TNF superfamily, member 2) (TNF)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
Tnf - KN2.0, Mouse gene knockout kit via CRISPR, non-homology mediated.
| Format | 2 gRNA vectors, 1 linear donor |
| Donor DNA | EF1a-GFP-P2A-Puro |
KN517964 is the updated version of KN317964.
Lenti ORF particles, Tnf (Myc-DDK-tagged) - Mouse tumor necrosis factor (Tnf), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF clone of Tnf (mGFP-tagged) - Mouse tumor necrosis factor (Tnf)
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF particles, Tnf (GFP-tagged) - Mouse tumor necrosis factor (Tnf), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Tnf (myc-DDK-tagged) - Mouse tumor necrosis factor (Tnf), transcript variant 2
| Vector | pCMV6-Entry |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Neomycin |
- TrueORF®
USD 820.00
3 Weeks
Lenti ORF particles, TNF (Myc-DDK tagged) - Human tumor necrosis factor (TNF), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF clone of Human tumor necrosis factor (TNF), mGFP tagged
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
USD 820.00
3 Weeks
Lenti ORF particles, TNF (mGFP-tagged) - Human tumor necrosis factor (TNF), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF clone of Tnf (Myc-DDK-tagged ORF) - Rat tumor necrosis factor (TNF superfamily, member 2) (Tnf), (10 ug)
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF particles, Tnf (Myc-DDK-tagged ORF) - Rat tumor necrosis factor (TNF superfamily, member 2) (Tnf), 200ul, >10^7 TU/mL
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF clone of Tnf (mGFP-tagged ORF) - Rat tumor necrosis factor (TNF superfamily, member 2) (Tnf), (10 ug)
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF particles, Tnf (GFP-tagged ORF) - Rat tumor necrosis factor (TNF superfamily, member 2) (Tnf), 200ul, >10^7 TU/mL
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
-
Lenti ORF clone of Human tumor necrosis factor (TNF), Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK |
| Tag | Myc-DDK |
| Mammalian Cell Selection | None |
- LentiORF®
3`UTR clone of tumor necrosis factor (TNF superfamily member 2) (TNF) for miRNA target validation
| Vector | pMirTarget |
| Mammalian Cell Selection | Neomycin |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
TNF - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector
| Format | Retroviral plasmids |
| Vector | pGFP-V-RS |
| E. coli Selection | Kanamycin |
| Mammalian Cell Selection | Puromycin |
qPCR primer pairs and template standards against Homo sapiens gene TNF
| Application | Plasmid of exact quantity for transcript copy number calculation |
Recombinant protein of human Tumor Necrosis Factor-a (TNFa) produced in E. coli.
| Tag | Tag Free |
| Expression Host | E. coli |
Tumor necrosis factor (TNF-alpha) (77-233) human recombinant protein, 0.5 mg
| Expression Host | E. coli |
Lenti ORF clone of Tnf (mGFP-tagged ORF) - Rat tumor necrosis factor (TNF superfamily, member 2) (Tnf), (10 ug)
| Vector | pLenti-C-mGFP |
| Tag | mGFP |
| Mammalian Cell Selection | None |
- LentiORF®
Purified recombinant protein of Mouse tumor necrosis factor (Tnf)
| Tag | Tag Free |
| Expression Host | E. coli |
Purified recombinant protein of Mouse tumor necrosis factor (Tnf).
| Tag | Tag Free |
| Expression Host | E. coli |
Lenti ORF clone of Tnf (Myc-DDK-tagged) - Mouse tumor necrosis factor (Tnf)
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
Lenti ORF clone of Human tumor necrosis factor (TNF), Myc-DDK-tagged
| Vector | pLenti-C-Myc-DDK-P2A-Puro |
| Tag | Myc-DDK |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
TNF (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
| Purity | HPLC purified |
| Number of Transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
Special offer: Get $100/€100 off this product. Use code: SR100
TNF - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
Recombinant protein of human tumor necrosis factor (TNF superfamily, member 2) (TNF), the soluble form (Val77 -Leu233)
| Tag | tag free |
| Expression Host | E. coli |
Purified recombinant protein of Rat tumor necrosis factor (TNF superfamily, member 2) (Tnf).
| Tag | Tag Free |
| Expression Host | E. coli |
TNF HEK293T cell transient overexpression lysate (as WB positive control)
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
| Applications | WB |
Tumor necrosis factor (TNF-alpha) human recombinant protein, 10 µg
| Expression Host | E. coli |
Active filters
Target Symbol
- TNF
Filter by
Species
Reactivities
Antibody Hosts
Clonalities
Conjugates
Expression Hosts
Lentivirus
Tags
Vectors
Modifications
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. (2)
- This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (2)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric mouse antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This is a chimeric antibody created for improved compatibility with existing reagents, assays and techniques. (1)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format, for improved compatibility with existing reagents, assays and techniques. (1)
- Unmodified (1)
Assay Types
Assay Platforms
QC Levels
Mammalian Cell Selection
Pathways
- Adipocytokine signaling pathway (96)
- Allograft rejection (96)
- Alzheimer's disease (96)
- Amyotrophic lateral sclerosis (ALS) (96)
- Apoptosis (96)
- Asthma (96)
- Cytokine-cytokine receptor interaction (96)
- Dilated cardiomyopathy (96)
- Fc epsilon RI signaling pathway (96)
- Graft-versus-host disease (96)
- Hematopoietic cell lineage (96)
- Hypertrophic cardiomyopathy (HCM) (96)
- MAPK signaling pathway (96)
- NOD-like receptor signaling pathway (96)
- Natural killer cell mediated cytotoxicity (96)
- RIG-I-like receptor signaling pathway (96)
- Systemic lupus erythematosus (96)
- T cell receptor signaling pathway (96)
- TGF-beta signaling pathway (96)
- Toll-like receptor signaling pathway (96)
- Type I diabetes mellitus (96)
- Type II diabetes mellitus (96)